Remove CFO Remove Corporate Finance Remove Pharmaceutical
article thumbnail

CFO Corner With SCHOTT Pharma’s Almuth Steinkühler

Global Finance

Almuth Steinkhler has been CFO of SCHOTT Pharma, which designs drug containment products and drug delivery systems for pharmaceutical and biotech companies, since August 2022. However, for a CFO, the real deal starts at day one after the listing day. Steinkhler previously worked at ThyssenKrupp and Continental AG.

CFO 52
article thumbnail

946: Using the Influence at Your Command | Natalie Laackman, CFO, MedSpeed

CFO Thought Leader

For corporate finance executives, few professional experiences are as adeptly converted into social currency as those manifested inside the realm of mergers and acquisitions (M&A). It seems that regardless of whether a finance executive has been involved in one deal or 40, they are usually able to quickly share a takeaway or two.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CFO Pros on the Move: March

The Finance Weekly

However, amidst this uncertainty, the need for qualified CFOs remains as crucial as ever. CFO Pros on the Move March 2023 Steve Nave | Funko Funko, the pop-culture toy company, has named , Steve Nave as its CFO and COO. Burke takes over from Brian Cooper, who assumed the CFO role in 2021. She is also a U.S. Army veteran.

CFO 52
article thumbnail

Musings on Markets: META Lesson 2: Accounting Inconsistencies and Consequences

CFO News Room

Accounting 101. I am not an accountant, and have no desire to be one, but I have used their output (accounting statements) as raw material in valuation and corporate finance.

article thumbnail

Musings on Markets: Data Update 5 for 2022: The Bottom Line!

CFO News Room

If you have been reading my posts for a while, you know that I find the corporate life cycle a useful device in explaining everything from what companies should focus on, in corporate finance, to the balance between stories and numbers, when investor value companies.

Marketing 130
article thumbnail

CFO Corner: Anne-Laure Autret-Cornet, OSE Immunotherapeutics

Global Finance

Since 2016, Anne-Laure Autret-Cornet has been the CFO of OSE Immunotherapeutics, a biotech dedicated to immuno-oncology and immuno-inflammation. Global Finance: What has been your biggest challenge as CFO? And we have ongoing important collaborations with other companies such as Boehringer Ingelheim and Veloxis Pharmaceuticals.

CFO 52
article thumbnail

The Difference Makers: Key Person(s) Valuation

Musings on Markets

As someone who teaches corporate finance, I have always tried to pass on the message, especially to those who are headed to finance jobs at companies or investment banks, that of all of the players in an organization, finance people are among the most replaceable, and thus least likely to be key people.

Valuation 128